Alnylam shares take a hit amid sluggish sales of first drug By: Boston Business Journal via Business Journals November 07, 2018 at 11:33 AM EST The drug, Onpattro, treats a rare disease that is difficult to diagnose, which poses a challenge for Alnylam in building a patient base. Read More >>
